HeartMate 3 recall and insufficient hearts for transplant make HF therapy landscape dire: GlobalData
According to GlobalData, there were over 7.8 million prevalent cases of HF in the US alone in 2023, registering a CAGR of 2 per…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
heart failure
Cardiac markers & extended lipid profile as risk stratification tool
*Dr Barnali Das talks about biomarker based cardiac care model and emphasises that laboratories must take on the responsibility of…
Value of NT-proBNP and Troponin in diagnosis & therapy management of heart failure patients
Express Healthcare in partnership with Radiometer Medical organised a live panel discussion on the Value of NT-proBNP and Troponin…
Cardiologists, ED specialists to discuss value of NT-proBNP, Troponin in diagnosis, therapy…
Four experts in cardiology and emergency services will share their experiences with these cardiac biomarkers and discuss why they…
AstraZeneca’s Dapagliflozin (Forxiga) gets marketing authorisation in India
The drug will be used to treat patients with heart failure
AstraZeneca Pharma India (AstraZeneca India), received the…
- Advertisement -
Biofourmis partners with Novartis
Both organisations will embark on a project to remotely manage heart failure patients to identify early signs of heart failure…